AAPL315.94-4.03 (-1.26%) ▼|ABBV251.02-5.44 (-2.12%) ▼|ABT105.72-2.61 (-2.41%) ▼|ACN178.68-8.05 (-4.31%) ▼|ADBE257.90-8.61 (-3.23%) ▼|AMAT470.10+15.39 (+3.38%) ▲|AMD508.05+30.48 (+6.38%) ▲|AMGN395.81-41.42 (-9.47%) ▼|AMT177.45+1.60 (+0.91%) ▲|AMZN257.21-1.30 (-0.50%) ▼|AVGO371.22+13.32 (+3.72%) ▲|AXP327.57+1.41 (+0.43%) ▲|BA215.19+2.94 (+1.39%) ▲|BAC62.65-0.04 (-0.06%) ▼|BKNG182.48-10.81 (-5.59%) ▼|BLK1,106.10-10.46 (-0.94%) ▼|BMY65.01-1.81 (-2.71%) ▼|BNY164.30-0.55 (-0.33%) ▼|BRK-B504.34-1.69 (-0.33%) ▼|C137.64-0.09 (-0.06%) ▼|CAT828.40+14.46 (+1.78%) ▲|CL88.20-0.57 (-0.64%) ▼|CMCSA26.15-0.35 (-1.30%) ▼|COF216.29-3.32 (-1.51%) ▼|COP135.48+1.22 (+0.91%) ▲|COST907.74-8.01 (-0.87%) ▼|CRM250.47-8.77 (-3.38%) ▼|CSCO109.38+0.18 (+0.16%) ▲|CVS95.76-0.98 (-1.02%) ▼|CVX211.10+2.50 (+1.20%) ▲|DE683.73-9.80 (-1.41%) ▼|DHR205.78-1.88 (-0.91%) ▼|DIS104.56-0.75 (-0.71%) ▼|DUK121.17+0.95 (+0.79%) ▲|EMR153.67+0.85 (+0.56%) ▲|FDX318.85-3.67 (-1.14%) ▼|GD356.23-3.17 (-0.88%) ▼|GE338.87+1.75 (+0.52%) ▲|GEV961.23+19.28 (+2.05%) ▲|GILD146.16-4.84 (-3.20%) ▼|GM85.74-2.02 (-2.30%) ▼|GOOG335.45+0.14 (+0.04%) ▲|GOOGL338.53+0.07 (+0.02%) ▲|GS1,039.75+1.14 (+0.11%) ▲|HD317.30-3.75 (-1.17%) ▼|HON208.59-1.02 (-0.49%) ▼|IBM232.56-2.33 (-0.99%) ▼|INTC104.17+8.37 (+8.74%) ▲|INTU314.87-17.83 (-5.36%) ▼|ISRG350.35-16.35 (-4.46%) ▼|JNJ267.95-7.28 (-2.65%) ▼|JPM356.50-2.15 (-0.60%) ▼|KO87.91-0.16 (-0.18%) ▼|LIN470.26-7.31 (-1.53%) ▼|LLY1,119.32-30.04 (-2.61%) ▼|LMT540.95+15.67 (+2.98%) ▲|LOW202.44-2.02 (-0.99%) ▼|LRCX321.09+13.44 (+4.37%) ▲|MA568.31-10.91 (-1.88%) ▼|MCD255.65-0.04 (-0.02%) ▼|MDLZ60.97-0.31 (-0.51%) ▼|MDT91.82-2.35 (-2.50%) ▼|META616.72-0.05 (-0.01%) ▼|MMM166.26-2.30 (-1.36%) ▼|MO67.93-0.95 (-1.38%) ▼|MRK148.31-2.02 (-1.34%) ▼|MS218.05+0.33 (+0.15%) ▲|MSFT492.98-6.72 (-1.34%) ▼|MU1,019.25+2.66 (+0.26%) ▲|NEE84.09+0.66 (+0.79%) ▲|NFLX76.62-1.63 (-2.09%) ▼|NKE38.17-0.24 (-0.61%) ▼|NOW135.35-5.91 (-4.18%) ▼|NVDA226.66-3.70 (-1.61%) ▼|ORCL164.53+5.75 (+3.62%) ▲|PEP137.98+0.35 (+0.25%) ▲|PFE27.87-0.58 (-2.04%) ▼|PG144.69-1.75 (-1.20%) ▼|PLTR171.34-2.99 (-1.72%) ▼|PM184.68+2.15 (+1.18%) ▲|QCOM176.10+7.36 (+4.36%) ▲|RTX198.64-2.16 (-1.07%) ▼|SBUX102.87-1.60 (-1.53%) ▼|SCHW108.08-1.22 (-1.11%) ▼|SO89.01+0.90 (+1.02%) ▲|SPG209.60+0.16 (+0.08%) ▲|T25.72+0.04 (+0.17%) ▲|TMO600.83-12.95 (-2.11%) ▼|TMUS180.58-0.94 (-0.52%) ▼|TSLA366.87+12.79 (+3.61%) ▲|TXN259.90+1.46 (+0.56%) ▲|UBER73.45-2.32 (-3.06%) ▼|UNH395.99-1.15 (-0.29%) ▼|UNP289.92+0.30 (+0.10%) ▲|UPS101.22-1.07 (-1.05%) ▼|USB62.86-0.52 (-0.81%) ▼|V368.13-6.94 (-1.85%) ▼|VZ50.32+0.18 (+0.35%) ▲|WFC88.76-1.22 (-1.35%) ▼|WMT106.06-1.08 (-1.01%) ▼|XOM159.62+0.15 (+0.09%) ▲|AAPL315.94-4.03 (-1.26%) ▼|ABBV251.02-5.44 (-2.12%) ▼|ABT105.72-2.61 (-2.41%) ▼|ACN178.68-8.05 (-4.31%) ▼|ADBE257.90-8.61 (-3.23%) ▼|AMAT470.10+15.39 (+3.38%) ▲|AMD508.05+30.48 (+6.38%) ▲|AMGN395.81-41.42 (-9.47%) ▼|AMT177.45+1.60 (+0.91%) ▲|AMZN257.21-1.30 (-0.50%) ▼|AVGO371.22+13.32 (+3.72%) ▲|AXP327.57+1.41 (+0.43%) ▲|BA215.19+2.94 (+1.39%) ▲|BAC62.65-0.04 (-0.06%) ▼|BKNG182.48-10.81 (-5.59%) ▼|BLK1,106.10-10.46 (-0.94%) ▼|BMY65.01-1.81 (-2.71%) ▼|BNY164.30-0.55 (-0.33%) ▼|BRK-B504.34-1.69 (-0.33%) ▼|C137.64-0.09 (-0.06%) ▼|CAT828.40+14.46 (+1.78%) ▲|CL88.20-0.57 (-0.64%) ▼|CMCSA26.15-0.35 (-1.30%) ▼|COF216.29-3.32 (-1.51%) ▼|COP135.48+1.22 (+0.91%) ▲|COST907.74-8.01 (-0.87%) ▼|CRM250.47-8.77 (-3.38%) ▼|CSCO109.38+0.18 (+0.16%) ▲|CVS95.76-0.98 (-1.02%) ▼|CVX211.10+2.50 (+1.20%) ▲|DE683.73-9.80 (-1.41%) ▼|DHR205.78-1.88 (-0.91%) ▼|DIS104.56-0.75 (-0.71%) ▼|DUK121.17+0.95 (+0.79%) ▲|EMR153.67+0.85 (+0.56%) ▲|FDX318.85-3.67 (-1.14%) ▼|GD356.23-3.17 (-0.88%) ▼|GE338.87+1.75 (+0.52%) ▲|GEV961.23+19.28 (+2.05%) ▲|GILD146.16-4.84 (-3.20%) ▼|GM85.74-2.02 (-2.30%) ▼|GOOG335.45+0.14 (+0.04%) ▲|GOOGL338.53+0.07 (+0.02%) ▲|GS1,039.75+1.14 (+0.11%) ▲|HD317.30-3.75 (-1.17%) ▼|HON208.59-1.02 (-0.49%) ▼|IBM232.56-2.33 (-0.99%) ▼|INTC104.17+8.37 (+8.74%) ▲|INTU314.87-17.83 (-5.36%) ▼|ISRG350.35-16.35 (-4.46%) ▼|JNJ267.95-7.28 (-2.65%) ▼|JPM356.50-2.15 (-0.60%) ▼|KO87.91-0.16 (-0.18%) ▼|LIN470.26-7.31 (-1.53%) ▼|LLY1,119.32-30.04 (-2.61%) ▼|LMT540.95+15.67 (+2.98%) ▲|LOW202.44-2.02 (-0.99%) ▼|LRCX321.09+13.44 (+4.37%) ▲|MA568.31-10.91 (-1.88%) ▼|MCD255.65-0.04 (-0.02%) ▼|MDLZ60.97-0.31 (-0.51%) ▼|MDT91.82-2.35 (-2.50%) ▼|META616.72-0.05 (-0.01%) ▼|MMM166.26-2.30 (-1.36%) ▼|MO67.93-0.95 (-1.38%) ▼|MRK148.31-2.02 (-1.34%) ▼|MS218.05+0.33 (+0.15%) ▲|MSFT492.98-6.72 (-1.34%) ▼|MU1,019.25+2.66 (+0.26%) ▲|NEE84.09+0.66 (+0.79%) ▲|NFLX76.62-1.63 (-2.09%) ▼|NKE38.17-0.24 (-0.61%) ▼|NOW135.35-5.91 (-4.18%) ▼|NVDA226.66-3.70 (-1.61%) ▼|ORCL164.53+5.75 (+3.62%) ▲|PEP137.98+0.35 (+0.25%) ▲|PFE27.87-0.58 (-2.04%) ▼|PG144.69-1.75 (-1.20%) ▼|PLTR171.34-2.99 (-1.72%) ▼|PM184.68+2.15 (+1.18%) ▲|QCOM176.10+7.36 (+4.36%) ▲|RTX198.64-2.16 (-1.07%) ▼|SBUX102.87-1.60 (-1.53%) ▼|SCHW108.08-1.22 (-1.11%) ▼|SO89.01+0.90 (+1.02%) ▲|SPG209.60+0.16 (+0.08%) ▲|T25.72+0.04 (+0.17%) ▲|TMO600.83-12.95 (-2.11%) ▼|TMUS180.58-0.94 (-0.52%) ▼|TSLA366.87+12.79 (+3.61%) ▲|TXN259.90+1.46 (+0.56%) ▲|UBER73.45-2.32 (-3.06%) ▼|UNH395.99-1.15 (-0.29%) ▼|UNP289.92+0.30 (+0.10%) ▲|UPS101.22-1.07 (-1.05%) ▼|USB62.86-0.52 (-0.81%) ▼|V368.13-6.94 (-1.85%) ▼|VZ50.32+0.18 (+0.35%) ▲|WFC88.76-1.22 (-1.35%) ▼|WMT106.06-1.08 (-1.01%) ▼|XOM159.62+0.15 (+0.09%) ▲|
25.3 C
New York
Tuesday, September 8, 2026

Tag: medications

newssourceFORcompanyinformationcontent1releasesmarket

Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

DUBLIN, July 21, 2025 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company focused on transforming medicines to transform lives, today announced that the Compensation Committee of Avadel’s Board of Directors approved the grant of non-statutory options to six (6) new employees to purchase 34,200 ordinary shares under Avadel’s 2021 Inducement Plan. The awards were granted as an inducement material to the employee’s acceptance of employment with Avadel in accordance with Nasdaq Listing Rule 5635(c)(4). The options have a ten-year term and vest over four years, with 25% vesting on the one-year anniversary of each new employee’s respective start date and 25% vesting on the second, third, and fourth anniversary thereafter. The options are subject to the terms and conditions of Avadel’s 2021 Inducement Plan approved by the Board of Directors in November 2021 and the terms and conditions of award agreements covering the grants.

Natural Appetite Suppressant: Why More Are Choosing PhenQ Over Weight Loss Injections for Safer Weight Management Results in 2025

New York City, NY, July 21, 2025 (GLOBE NEWSWIRE) -- PhenQ is leading the 2025 weight loss revolution with a science-backed natural appetite suppressant—no needles, no harsh side effects, just sustainable, healthy weight control

Workout Routine For Men Revealed: How To Build Muscle Fast With CrazyBulk Muscle Gaining Supplements

Discover the ultimate workout routine for men and learn how to build muscle fast with expert training tips, CrazyBulk stacks, and muscle gaining supplements. Get actionable strategies and science-backed advice for rapid results, maximum strength, and a lean, powerful physique. 
Discover the ultimate workout routine for men and learn how to build muscle fast with expert training tips, CrazyBulk stacks, and muscle gaining supplements. Get actionable strategies and science-backed advice for rapid results, maximum strength, and a lean, powerful physique.

EURneffy® (adrenaline nasal spray) Approved in the U.K. as the First and Only Needle-Free Emergency Treatment of Allergic Reactions (anaphylaxis)

EURneffy (neffy® in the U.S.) offers a new delivery method for adrenaline in the U.K. for adults and children (>30 kg) living with severe allergic reactions

Nature Medicine Published Phase 1 Results of Innovent Biologics’ Anti-CLDN18.2 ADC (IBI343) in Patients with Advanced Gastric/Gastroesophageal Junction Adenocarcinoma

SAN FRANCISCO and SUZHOU, China, July 16, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality...

Peanut Allergy Market Set to Grow at a 16% CAGR During the Study Period (2020-2034) Owing to Current Usage of Epinephrine, Anticipated Usage of...

The evolving peanut allergy treatment market landscape features clinical trials led by DBV Technologies (Viaskin Peanut Patch), Novartis (Remibrutinib), Aravax (PVX108), ALK-Abello (Sublingual...

Blue Circle Health expands type 1 diabetes care program to Louisiana

Free type 1 diabetes clinical care, education, and support program for adults is now operating in Louisiana.Designed to improve health outcomes and empower individuals...

RxPreferred Launches My-RxP: Cutting Costs for Brand, Specialty, GLP-1, and Fertility Medications by Up to 60%

NASHVILLE, Tenn., July 16, 2025 /PRNewswire/ -- RxPreferred, a leading transparent pharmacy benefit administrator, is proud to announce the launch of My-RxP, an innovative medication...

Henry Ford Health Initiates Patient Enrollment for BioCardia’s CardiAMP HF II Pivotal Study for Ischemic Heart Failure of Reduced Ejection Fraction

SUNNYVALE, Calif., July 16, 2025 (GLOBE NEWSWIRE) -- BioCardia, Inc. [Nasdaq: BCDA], a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, announced today that Henry Ford Health in Detroit, Michigan is now enrolling patients with ischemic HFrEF in the Company’s ongoing pivotal CardiAMP HF II trial.

Liviniti Technology Wins Platinum Pinnacle Award

Purpose-built, cloud-based technology enables full PBM transparency with complete visibility, advanced data analytics and a flexible approach NATCHITOCHES, La., July 16, 2025 /PRNewswire/ -- Liviniti,...

Cleanfarms to Launch Recycling Program for Pesticide and Fertilizer Containers in Newfoundland

New this year, Newfoundland farmers can bring their empty pesticide and fertilizer containers 23L and under to Cleanfarms collection events to be recycled.

Icy Hot® & The Shaquille O’Neal Foundation Launch Latest Comebaq Court, in Partnership with Boys & Girls Club of Northeast Texas

ROCKWALL, Texas, July 15, 2025 /PRNewswire/ -- On July 14th, Icy Hot, an Opella Brand, and The Shaquille O'Neal Foundation announced the opening of their...

Branded Legacy Inc. Announces Leadership Transition and Pending Merger with Innovative Addiction Therapeutics Company Projecting $40 Million in First-Year Revenue

ORLANDO, Fla., July 14, 2025 (GLOBE NEWSWIRE) -- via IBN -- Branded Legacy Inc. (OTC: BLEG), a diversified holdings company, today announced significant changes in its leadership structure and a strategic merger initiative aimed at positioning the company for growth in the burgeoning addiction therapeutics sector.

HIMS FRAUD CLASS ACTION: Hims & Hers Health, Inc. Investors may have been Affected by Fraud – Contact BFA Law by August 25 Legal...

Hims & Hers Health, Inc. investors that lost money are notified to contact BFA Law before the August 25, 2025 securities fraud class action deadline.

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsMedications

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers